0Y7T Allergan Plc

TIDM0Y7T

RNS Number : 6220A

Franklin Resources, Inc

22 January 2020

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

   1.       KEY INFORMATION 
 
Name of person dealing       Franklin Resources, Inc. 
 (Note 1) 
Company dealt in             Allergan plc 
                            =========================== 
Class of relevant security 
 to which the dealings        US$0.0001 ordinary shares 
 being disclosed relate 
 (Note 2) 
                            =========================== 
Date of dealing              21 January 2020 
                            =========================== 
 
   2.         INTERESTS AND SHORT POSITIONS 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 
                                         Long                Short 
                             Number       (%)     Number       (%) 
                             ==========  ======  ===========  ====== 
(1) Relevant securities       7,279,603 2.22% 
                             ==================  =================== 
(2) Derivatives (other 
 than options) 
                             ==================  =================== 
(3) Options and agreements 
 to purchase/sell 
                             ==================  =================== 
Total                         7,279,603 2.22% 
                             ==================  =================== 
 
 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 
Class of relevant security:                Long                Short 
                              Number        (%)     Number         (%) 
                              =========    ======  ===========    ====== 
(1) Relevant securities 
                              ===================  ===================== 
 
  (2) Derivatives (other 
  than options) 
                              ===================  ===================== 
 
  (3) Options and agreements 
  to purchase/sell 
                              ===================  ===================== 
Total 
                              ===================  ===================== 
 
 

Ap20

   1.       DEALINGS (Note 4) 
   (a)      Purchases and sales 
 
 
  Purchase/sale           Number of relevant securities        Price per unit 
                                                               (Note 5) 
Sale                               65                         192.94 USD 
                 ======================================  ==================== 
 
   (b)      Derivatives transactions (other than options transactions) 
 
Product    Nature of transaction  Number of relevant   Price per 
 name,      (Note 6)               securities           unit 
 e.g. CFD                          (Note 7)             (Note 5) 
 
 
   (c)      Options transactions in respect of existing relevant securities 
   (i)       Writing, selling, purchasing or varying 
 
Product     Writing,      Number of       Exercise  Type,            Expiry  Option 
 name,       selling,      securities      price     e.g. American,   date    money 
 e.g. call   purchasing,   to which                  European                 paid/received 
 option      varying       the option                etc.                     per unit 
             etc.          relates (Note                                      (Note 
                           7)                                                 5) 
 
 
   (ii)      Exercising 
 
Product name,             Number of securities      Exercise price 
 e.g. call option                                    per unit (Note 
                                                     5) 
 
 
   (d)      Other dealings (including transactions in respect of new securities) (Note 4) 
 
Nature of transaction         Details      Price per unit 
 (Note 8)                                   (if applicable) 
                                            (Note 5) 
 
 

Ap21

   2.       OTHER INFORMATION 

Agreements, arrangements or understandings relating to options or derivatives

 
 
   Full details of any agreement, arrangement 
   or understanding between the person disclosing 
   and any other person relating to the voting 
   rights of any relevant securities under any 
   option referred to on this form or relating 
   to the voting rights or future acquisition 
   or disposal of any relevant securities to 
   which any derivative referred to on this form 
   is referenced. If none, this should be stated. 
 
 
   None 
 
   Is a Supplemental Form 8 attached? (Note 9)                                            NO 
 
Date of disclosure           22 January 2020 
Contact name                  Cathy Johnson 
                             ================================================ 
Telephone number              954-527-7580 subsshholder@franklintempleton.com 
                             ================================================ 
If a connected EFM, name 
 of offeree/offeror with       N/A 
 which connected 
                             ================================================ 
If a connected EFM, state 
 nature of connection (Note    N/A 
 10) 
                             ================================================ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ISEFLFSVLIIFFII

(END) Dow Jones Newswires

January 22, 2020 08:43 ET (13:43 GMT)

Allergan (LSE:0Y7T)
Historical Stock Chart
From Mar 2024 to Apr 2024

Allergan (LSE:0Y7T)
Historical Stock Chart
From Apr 2023 to Apr 2024